Keywords: xanthus, xanafide, sees, good, safety, data, cancer

Xanthus' Xanafide sees good safety data

Article | 30 May 2005

Print This

US cancer specialist Xanthus Life Sciences has revealed positive data from a Phase I study of Xanafide (amonafide) in combination ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in